Expression of estrogen and progesterone receptor genes in endometrium, myometrium and vagina of postmenopausal women treated with estriol

Sao Paulo Medical Journal

Volumn 127, Issue 3, 2009, Pages 128-133

  Bryś, Magdalena ^a   Szyłło, Krzysztof ^a,b   Romanowicz Makowska, Hanna ^a,b   Dobrowolski, Zbigniew ^a,b   Masłowska, Izabela ^a   Krajewska, Wanda ^a  

^a UNIVERSITY OF LODZ   (Poland)

^b POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

Author keywords

Estriol; Hormone replacement therapy; Receptors, estrogen; Receptors, progesterone; Reverse transcriptase polymerase chain reaction

Indexed keywords

BETA 2 MICROGLOBULIN; ESTRIOL; ESTROGEN RECEPTOR; MESSENGER RNA; PROGESTERONE RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIUM; ENDOMETRIUM ATROPHY; FEMALE; GENE EXPRESSION; HORMONAL REGULATION; HORMONE SUBSTITUTION; HUMAN; HUMAN TISSUE; MENSTRUAL CYCLE; MYOMETRIUM; PLASTIC SURGERY; POSTMENOPAUSE; RECEPTOR GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT DURATION; UTERUS PROLAPSE; VAGINA;

AGED; CROSS-SECTIONAL STUDIES; ENDOMETRIUM; ESTRIOL; FEMALE; GENE EXPRESSION; HUMANS; MIDDLE AGED; MYOMETRIUM; POSTMENOPAUSE; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RNA, MESSENGER; VAGINA;

EID: 70849111064     PISSN: 15163180     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-31802009000300004     Document Type: Article

References (39)

1. World Health Organization. Research on the menopause in the 1990s. Report of a WHO Scientific Group. Technical Report Series, No 866. Geneva: World Health Organization; 1996.
2. Rich RL, Hoth LR, Geoghegan KF, et al. Kinetic analysis of estrogen receptor/ligand interactions. Proc Natl Acad Sci U S A. 2002;99(13):8562-8567
3. Peck JD, Hulka BS, Poole C, Savitz DA, Baird D, Richardson BE. Steroid hormone levels during pregnancy and incidence of maternal breast cancer. Cancer Epidemiol Biomarkers Prev. 2002;11(4):361-368
4. Fujimoto J, Sakaguchi H, Aoki I, Toyoki H, Tamaya T. Clinical implications of the expression of estrogen receptor-alpha and -beta in primary and metastatic lesions of uterine endometrial cancers. Oncology. 2002;62(3):269-277 (Pubitemid 34639061)
5. Ito K, Utsunomiya H, Yaegashi N, Sasano H. Biological roles of estrogen and progesterone in human endometrial carcinoma-new developments in potential endocrine therapy for endometrial cancer. Endocr J. 2007;54(5):667-679
6. Hanstein B, Beckmann MW, Bender HG. Charakterisierung und Bedeutung verschiedener Ostrogenrezeptortypen unter besonderer Berücksichtigung des Endometriumkarzinoms [Role of estrogen receptor isoforms in the pathogenesis and treatment of endometrial cancer]. Zentralbl Gynakol. 2002;124(1):17-19
7. Jazaeri AA, Nunes KJ, Dalton MS, Xu M, Shupnik MA, Rice LW. Well-differentiated endometrial adenocarcinomas and poorly differentiated mixed mullerian tumors have altered ER and PR isoform expression. Oncogene. 2001;20(47):6965-6969 (Pubitemid 33052187)
8. Gräser T, Koytchev R, Müller A, Oettel M. Comparison of the efficacy and endometrial safety of two estradiol valerate/dienogest combinations and Kliogest for continuous combined hormone replacement therapy in postmenopausal women. Climacteric. 2000;3(2):109-118
9. Kajta M, Budziszewska B, Marszal M, Lason W. Effects of 17-beta estradiol and estriol on NMDA-induced toxicity and apoptosis in primary cultures of rat cortical neurons. J Physiol Pharmacol. 2001;52(3):437-446 (Pubitemid 32946282)
10. Parker MG, Arbuckle N, Dauvois S, Danielian P, White R. Structure and function of the estrogen receptor. Ann N Y Acad Sci. 1993;684:119-126
11. Le Marchand L, Donlon T, Kolonel LN, Henderson BE, Wilkens LR. Estrogen metabolism-related genes and breast cancer risk: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev. 2005;14(8):1998-2003. (Pubitemid 41161214)
12. Yu J, Yu J, Cordero KE, et al. A transcriptional fingerprint of estrogen in human breast cancer predicts patient survival. Neoplasia. 2008;10(1):79-88. (Pubitemid 351170715)
13. Klein-Hitpass L, Schwerk C, Kahmann S, Vassen L. Targets of activated steroid hormone receptors: basal transcription factors and receptor interacting proteins. J Mol Med. 1998;76(7):490-496 (Pubitemid 28261258)
14. Kano H, Hayashi T, Sumi D, et al. Estriol retards and stabilizes atherosclerosis through an NO-mediated system. Life Sci. 2002;71(1):31-42. (Pubitemid 34518627)
15. Taylor M. Unconventional estrogens: estriol, biest, and triest. Clin Obstet Gynecol. 2001;44(4):864-879 (Pubitemid 33115833)
16. Teede HJ, Liang YL, Kotsopoulos D, Zoungas S, Cravent R, McGrath BP. A placebo-controlled trial of long-term oral combined continuous hormone replacement therapy in postmenopausal women: effects on arterial compliance and endothelial function. Clin Endocrinol (Oxf). 2001;55(5):673-682 (Pubitemid 34204451)
17. Pardini D. Terapia hormonal da menopausa [Menopausal hormone therapy]. Arq Bras Endocrinol Metabol. 2007;51(6):938-942
18. Estevão RA, Baracat EC, Logullo AF, Oshima CT, Nazário AC. Efficacy of estriol in inhibiting epithelial proliferation in mammary fibroadenoma: randomized clinical trial. Sao Paulo Med J. 2007;125(6):343-350
19. Estevão RA, Nazário AC, Baracat EC. Effect of oral contraceptive with and without associated estriol on ultrasound measurements of breast fibroadenoma: randomized clinical trial. Sao Paulo Med J. 2007;125(5):275-280
20. Henriksson L, Stjernquist M, Boquist L, Alander U, Selinus I. A comparative multicenter study of the effects of continuous low-dose estradiol released from a new vaginal ring versus estriol vaginal pessaries in postmenopausal women with symptoms and signs of urogenital atrophy. Am J Obstet Gynecol. 1994;171(3):624-632 (Pubitemid 24312340)
21. van Haaften M, Donker GH, Sie-Go DM, Haspels AA, Thijssen JH. Biochemical and histological effects of vaginal estriol and estradiol applications on the endometrium, myometrium and vagina of postmenopausal women. Gynecol Endocrinol. 1997;11(3):175-185
22. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162(1):156-159 (Pubitemid 17064313)
23. Chevillard S, Müller A, Levalois C, Lainé-Bidron C, Vielh P, Magdelénat H. Reverse transcription-polymerase chain reaction (RT-PCR) assays of estrogen and progesterone receptors in breast cancer. Breast Cancer Res Treat. 1996;41(1):81-89 (Pubitemid 26360137)
24. Bassam BJ, Caetano-Anollés G, Gresshoff PM. Fast and sensitive silver staining of DNA in polyacrylamide gels. Anal Biochem. 1991;196(1):80-83
25. Latchman DS. Eukaryotic transcription factors. 2nd ed. London: Academic Press; 1995.
26. Latchman DS. Transcription factors: an overview. Int J Biochem Cell Biol. 1997;29(12):1305-1312
27. McDonnell DP, Clemm DL, Hermann T, Goldman ME, Pike JW. Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens. Mol Endocrinol. 1995;9(6):659-669
28. McDonnell DP, Clemm DL, Imhof MO. Definition of the cellular mechanisms which distinguish between hormone and antihormone activated steroid receptors. Semin Cancer Biol. 1994;5(5):327-336
29. Pardini D. Terapêutica de reposição hormonal na osteoporose da pós-menopausa [Hormonal replacement therapy in osteoporosis of postmenopausal]. Arq Bras Endocrinol Metab. 1999;43(6):428-432
30. Tzukerman MT, Esty A, Santiso-Mere D, et al. Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol Endocrinol. 1994;8(1):21-30.
31. Webb P, Lopez GN, Uht RM, Kushner PJ. Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol Endocrinol. 1995;9(4):443-456
32. Graham JD, Clarke CL. Physiological action of progesterone in target tissues. Endocr Rev. 1997;18(4):502-519
33. Wlaźlak E, Surkont G, Suzin J. Estradiol - nowość czy standard w terapii dopochwowej. Przegla̧d Menopauzalny. 2004;5(2):50-56 Available from: http://www.termedia.pl/magazine.php?magazine-id= 4&article-id=2640&magazine-subpage=ABSTRACT. Accessed in 2009 (Jun 15).
34. Kumar MV, Tindall DJ. Transcriptional regulation of the steroid receptor genes. Prog Nucleic Acid Res Mol Biol. 1998;59:289-306.
35. Gerbaldo D, Ferraiolo A, Croce S, Truini M, Capitanio GL. Endometrial morphology after 12 months of vaginal oestriol therapy in post-menopausal women. Maturitas. 1991;13(4):269-274
36. Ciszko B, Zdrojewicz Z. Znaczenie endogennego i egzogennego estriolu w praktyce klinicznej [Compliance endogenous and exogenous estriol in clinical practice]. Ginekol Pol. 2006;77(7):559-565
37. Englund DE, Johansson ED. Endometrial effect of oral estriol treatment in postmenopausal women. Acta Obstet Gynecol Scand. 1980;59(5):449-451
38. Van Gorp T, Neven P. Endometrial safety of hormone replacement therapy: review of literature. Maturitas. 2002;42(2):93-104. (Pubitemid 34632674)
39. Weiderpass E, Baron JA, Adami HO, et al. Low-potency oestrogen and risk of endometrial cancer: a case-control study. Lancet. 1999;353(9167):1824-1828 (Pubitemid 29251013)